To develop and internally validate a self-checkable screening tool for chronic prostatitis (CP) to facilitate diagnosis and treatment in the general population, addressing existing diagnostic challenges.
Key Findings:
Chronic prostatitis affects 1.8–9.7% of the male population and significantly impairs quality of life, highlighting the need for effective screening.
The developed S-CP tool consists of 16 critical items across three domains, aimed at improving diagnosis rates.
The tool aims to improve diagnosis rates and encourage medical consultation among those with CP-like symptoms.
Interpretation:
The S-CP tool provides a structured approach for identifying potential CP cases in the general population, addressing the diagnostic challenges faced by healthcare providers.
Limitations:
The study was limited to Japanese-speaking participants, which may affect generalizability to non-Japanese populations.
The reliance on self-reported data may introduce bias in symptom reporting, potentially affecting the accuracy of the findings.
Conclusion:
The S-CP screening tool has the potential to enhance the identification and management of chronic prostatitis in the general population, ultimately improving patient outcomes, but further validation in diverse populations is necessary.
